Strumento inattivo

Azioni SCHERING-PLOUGH

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India	02/11/09
SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies	02/11/09
SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma	30/10/09
SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices	29/10/09
SCHERING-PLOUGH : troisième trimestre en ligne avec les attentes	22/10/09

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-4,66%	86,13 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,32%	39,82 Mrd
BIOGEN INC.	-19,27%	30,42 Mrd
UCB	+57,86%	25,23 Mrd
BIOMARIN PHARMACEUTICAL INC.	-16,09%	15,35 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,14%	11,95 Mrd
INCYTE CORPORATION	-17,69%	11,6 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,00%	11,51 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,24%	8,71 Mrd